SEC Filing Summary: BioSig Technologies, Inc. (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on November 7, 2023, reporting an event that occurred on November 2, 2023. The company is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Executive Appointment: Frederick Hrkac was appointed as Executive Vice President, effective November 2, 2023.
- Committee Change: As a result of the appointment, James Klein was replaced as a member and Chairman of the nominating and corporate governance committee.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, specific risks, contingencies, or unusual items. The document serves solely to disclose the personnel changes noted above.
Investor Verification Checklist
- Verify the full text of the press release attached as Exhibit 99.1 for details on Mr. Hrkac's background and strategic role.
- Confirm the updated composition of the nominating and corporate governance committee in subsequent filings.
- Review the company's most recent 10-Q or 10-K for actual financial performance metrics, as this 8-K does not include them.